FDA Limits Authorized Use Of Johnson & Johnson Cor
Post# of 123460
Quote:
The FDA said in a statement, “After conducting an updated analysis, evaluation and investigation of reported cases, the FDA has determined that the risk of thrombosis with thrombocytopenia syndrome (TTS), a syndrome of rare and potentially life-threatening blood clots in combination with low levels of blood platelets with onset of symptoms approximately one to two weeks following administration of the Janssen COVID-19 Vaccine, warrants limiting the authorized use of the vaccine.”
https://www.dailywire.com/news/fda-limits-aut...lood-clots